Ah, the financial markets. A bastion of calm, predictable logic, right? Not when President Donald J. Trump is at the helm, it seems. The past few weeks alone have delivered a dizzying array of pronouncements, threats, and “historic deals” that would give even the most seasoned investor a case of whiplash. From tariffs that swing like a pendulum to drug price cuts that send pharmaceutical giants scrambling, the market’s relationship with the current administration remains, shall we say, complicated. It’s less a steady hand on the tiller and more a high-stakes game of economic whack-a-mole, where every presidential tweet or press conference sends ripples, if not tsunamis, through portfolios worldwide.
The Tariff Tango: A Tax by Any Other Name
Let’s start with the perennial favorite: tariffs. Just when you thought the global trade landscape might settle into a semblance of order, President Trump has once again proven that stability is merely a suggestion. The recent threat of a sweeping 155% tariff on Chinese imports, set to kick in on November 1, 2025, if a new trade deal isn’t struck, has certainly kept analysts busy. This isn’t just idle chatter; similar threats earlier in 2025, when tariffs on Chinese goods were raised to 100%, triggered a substantial market crash. On October 10, 2025, the S&P 500 plummeted 2.7%, the Dow Jones Industrial Average dropped a hefty 878 points (1.9%), and the tech-heavy Nasdaq Composite slid 3.6%, effectively erasing a month’s worth of gains. Major tech players like Amazon, Nvidia, and Tesla were among the hardest hit.
It’s a familiar tune. Back on April 2, 2025, President Trump announced a 10% universal tariff on all imports, alongside “reciprocal” tariffs on dozens of countries, some soaring as high as 50%. Global markets, naturally, plunged in response. Fast forward to June 4, 2025, and tariffs on steel and aluminum were dramatically doubled to 50%. While this might sound like a blow, domestic steelmakers actually saw a surge. Shares of Cleveland-Cliffs (CLF) jumped 14% and Nucor (NUE) advanced 8% soon after markets opened, boosting the VanEck Steel ETF (SLX) by 3%. One man’s trade war is another man’s profit margin, apparently.
And then there’s the rather innovative concept of the “$2,000 tariff dividend.” President Trump, in a move that has economists scratching their heads, proposed using tariff revenues to send payments to U.S. households. He declared on Truth Social, his social media platform, that “A dividend of at least $2,000 a person (not including high income people!) will be paid to everyone”. However, analysts are quick to point out a slight snag in this grand plan: tariffs are, in essence, a tax on consumers. The Tax Foundation estimates that the average household lost between $1,200 and $1,600 in income due to tariffs in 2025 and 2026, with Yale Budget Lab citing a loss of $1,800. So, a $2,000 check might sound nice, but if households are already paying more for goods, the net gain could be a rather modest $200 to $800. It’s the economic equivalent of giving someone a dollar after you’ve taken two. Goldman Sachs analysts, ever the pragmatists, predict that changes to U.S. trade policy could subtract 0.4% from global GDP, with a 10% across-the-board tariff potentially tripling that impact. They also note that tariffs are largely passed on to consumer prices, raising inflation. The Supreme Court is currently reviewing the legality of these International Emergency Economic Powers Act (IEEPA) tariffs, adding another layer of suspense to this thrilling economic drama.
Amidst the tariff threats, there have also been “historic trade deals.” On November 13, 2025, President Trump announced breakthrough agreements with El Salvador, Argentina, Ecuador, and Guatemala, aimed at reducing tariff and non-tariff barriers and expanding market access for American exporters in the Western Hemisphere. The market’s reaction to these specific deals, however, has been less dramatic than the tariff announcements, perhaps indicating a growing fatigue with the constant ebb and flow of trade rhetoric.
The Pharmaceutical Rollercoaster: Discounting Health, One Tweet at a Time
The pharmaceutical industry has also found itself squarely in the crosshairs of presidential policy. President Trump recently announced deals with pharmaceutical giants Eli Lilly (LLY) and Novo Nordisk (NVO) to significantly lower the prices of popular GLP-1 drugs like Ozempic, Wegovy, and Zepbound. These reductions, set to be available for Medicare and Medicaid recipients, as well as cash payers, through a new government platform called “TrumpRx,” are slated to launch in January 2026.
The market’s initial reaction to these pronouncements was, predictably, a bit of a scramble. On October 17, 2025, when President Trump first commented on lowering Ozempic prices to a suggested $150 out-of-pocket, Novo Nordisk shares dropped a notable 7%, while Eli Lilly shares fell 4.3%. Investors, it seems, aren’t keen on the idea of reduced revenue, even if it’s for the greater good of cheaper medication. However, after the formal deal announcement on November 7, 2025, the picture became a little clearer. Eli Lilly‘s stock closed up 1.26%, while Novo Nordisk lagged, down 3.31%, likely due to lingering investor concerns over potential lost revenue. By Monday afternoon, November 10, Lilly had surged almost 4.73%, with Novo seeing a modest gain of 0.33%. It appears that once the shock wears off and the details emerge, the market can, eventually, adjust. The administration also announced plans to lower the cost of IVF drugs, which saw Progyny (PGNY), a provider of fertility benefits, jump after the news.
Housing’s Long and Winding Road: The 50-Year Mortgage Saga
Not content with merely reshaping trade and healthcare, President Trump has also turned his attention to the American dream of homeownership, proposing a rather novel solution: the 50-year mortgage. On November 8, 2025, the President floated this idea via his Truth Social platform. Federal Housing Finance Agency Director Bill Pulte enthusiastically confirmed that his agency was indeed working on this, hailing it as a “complete game changer”.
While the prospect of lower monthly payments might sound appealing, financial experts and even some of the President’s own conservative base have been quick to point out the rather significant drawbacks. Experts warn that while monthly payments might decrease, the total interest paid over five decades would be “staggering,” potentially doubling the interest paid on a traditional 30-year mortgage. Joel Berner, a senior economist at Realtor.com, calculated that on a $360,000 loan, a 50-year term with a 6.25% rate would save only about $250 a month but accrue approximately $816,000 in interest, nearly double the $438,000 for a 30-year term. Furthermore, homebuyers would build equity at an “incredibly slow pace”. The proposal has even drawn “furious backlash” from “MAGA friends” who argue it’s a “giveaway to the banks” and prolongs the time it takes for Americans to truly own their homes. President Trump, however, remains unfazed, shrugging off the criticism with a simple, “All it means is you pay less per month”.
The Truth (Social) About Volatility
In this era of constant policy pronouncements, it’s worth noting the platform from which many of these pronouncements emanate: Truth Social. President Trump frequently uses his social media platform to share his thoughts on tariffs, economic policies, and more. The company behind Truth Social, Digital World Acquisition Corp. (DWAC), which merged with Trump Media & Technology Group (TMTG) in March 2024 and now trades under the ticker DJT, has seen its own share of market drama. Forecasts for DWAC (now DJT) stock for December 10, 2025, predict a potential drop of -24.36% to $37.78 per share, despite a “Bullish” sentiment from technical indicators, while the “Fear & Greed Index” signals “Fear”. With a market cap of $3.58 billion as of November 11, 2025, and a 30-day price volatility of 8.68%, it seems even the platform itself embodies the very market uncertainty it often generates.
Conclusion: The Only Constant is Change (and Tweets)
The past few weeks have been a microcosm of the “Trump effect” on stock markets: a blend of dramatic announcements, immediate market jitters, and a subsequent, often contradictory, re-evaluation. While U.S. equity markets have shown resilience in 2025, rebounding strongly from an early downturn, recent volatility has picked up, fueled by concerns over artificial intelligence spending and Federal Reserve interest rate uncertainty. The recent government shutdown, which ended on November 13, 2025, also added to investor nervousness by delaying crucial economic data. On November 13, 2025, major indexes ended sharply lower, with the Dow shedding nearly 800 points (1.65%), the S&P 500 down 1.66%, and the Nasdaq declining 2.29%—their worst single-day performance in over a month.
Ultimately, the Trump administration’s impact on the stock market is less about a steady hand and more about a constant, unpredictable stream of headline-grabbing policy shifts. Investors, it seems, have learned to brace for impact, sift through the rhetoric, and perhaps, keep a sense of humor. Because in an economy where a single social media post can send shares tumbling or soaring, the only predictable thing is the sheer unpredictability of it all.
DISCLAIMER: We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.
Elana Harper is a seasoned financial editor and market analyst with over a decade of experience covering global equities, economic trends, and corporate earnings. Known for her sharp insights, Elana specializes in making complex financial topics accessible to a broad audience. She now serves as the Senior Financial Editor at Stock Market Watch, where she oversees daily market coverage and political commentary.